Genesis HealthCare (GEN) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Genesis HealthCare Reports Third Quarter 2015 Results
November 5, 2015 4:12 PM ESTKENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ --Â
Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 MillionGenesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More
Genesis HealthCare Reports Third Quarter 2015 Results
November 5, 2015 4:04 PM ESTKENNETT SQUARE, Pa., Nov. 5, 2015 /PRNewswire/ --Â
Strong Third Quarter Performance and Growth With Pro Forma1 Adjusted: EBITDAR of $188.8 Million, up 6.3% from Prior Year Quarter EBITDA of $67.2 Million, up 13.1% from Prior Year Quarter Diluted EPS of $0.07 Recent HUD Financing Approval Advances Balance Sheet Restructuring Initiatives; Expected to Improve Annual Free Cash Flow $25 - $30 MillionGenesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United... More
